CHRN Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.510.0% YoY
Profit margin-86.2%TECHNOLOGY
Market cap$3.31BMid cap

Valuation

Forward P/E
PEG ratio
P/B
30.02
P/S (TTM)
39.26
EV/EBITDA
123.39

Profitability & growth

ROE (TTM)
0.0%
Operating margin
-39.4%
Revenue growth YoY
0.0%
Dividend yield
Beta
1.03
Last earnings
Apr 28, 2026 · Reported $-2.04
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About ChronoScale Corporation

ChronoScale Corporation (Ticker: CHRN) is an innovative biotechnology firm committed to advancing healthcare through the development and commercialization of groundbreaking therapeutics targeted at unmet medical needs. With a strong pipeline bolstered by strategic partnerships and a focus on leveraging cutting-edge technology, CHRN is poised to make significant contributions to patient care and drive advancements in the industry. Its dedication to scientific rigor and excellence positions the company to capitalize on emerging opportunities within the fast-evolving healthcare sector,…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
3811 TURTLE CREEK BLVD., DALLAS, TX
Fiscal year end
May
Latest quarter
May 31, 2025
Market cap$3.31B
Shares outstanding$143.1M
52W high$24.00
52W low$2.73

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer